Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor
Schipper, J.H.; Schrader, M.; Arweiler, D.; Müller, S.; Sciuk, J.
Hno 44(5): 254-257
1996
ISSN/ISBN: 0017-6192 PMID: 8707630 Document Number: 467564
In a prospective study 16 patients with cervical lymph node metastases from an occult tumor were analyzed by (18F)FDG positron emission tomography (PET). The aim of this study was to locate the primary tumor. In 7 patients a localized increase in activity was seen on PET, with this site of activity histologically proven in 4 patients. No biopsies were taken in 3 patients in areas with a high risk of complications. In a follow-up procedure at 2-22 months after primary radiation therapy in the other 9 patients, no primary tumor has been identified to date.
Document emailed within 1 workday
Related Documents
Tamam, M.O.; Mulazimoglu, M.; Guveli, T.K.; Tamam, C.; Eker, O.; Ozpacaci, T. 2012: Prediction of survival and evaluation of diagnostic accuracy whole body 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the detection carcinoma of unknown primary origin European Review for Medical and Pharmacological Sciences 16(15): 2120-2130Li, S.-j.; Guo, W.; Liao, J.-x.; Ren, G.-x. 2009: Evaluation of fluorodeoxyglucose-position-emission tomography-computer tomography imaging on head and neck squamous cell carcinomas including primary tumors and lymph node metastases Zhonghua Kou Qiang Yi Xue Za Zhi 44(10): 601-605
Keiding, S.; Hansen, S.B.; Rasmussen, H.H.; Gee, A.; Kruse, A.; Roelsgaard, K.; Tage-Jensen, U.; Dahlerup, J.F. 2000: Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography Ugeskrift for Laeger 162(6): 782-785
Tanigawa, N.; Mizuno, Y.; Hashimura, T.; Honda, K.; Satomura, K.; Hikasa, Y.; Niwa, O.; Sugahara, T.; Yoshida, O.; Kern, D.H. 1984: Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony-forming assay Cancer Research 44(6): 2309-2312
Mantaka, P.; Strauss, A.D.; Strauss, L.G.; Moehler, M.; Goldschmidt, H.; Oberdorfer, F.; Kontaxakis, G.; Van Kaick, G. 1999: Detection of treated liver metastases using fluorine-18-fluordeoxyglucose (FDG) and positron emission tomography (PET) Anticancer Research 19(5c): 4443-4450
Kosugi, C.; Saito, N.; Murakami, K.; Ochiai, A.; Koda, K.; Ono, M.; Sugito, M.; Ito, M.; Oda, K.; Seike, K.; Miyazaki, M. 2008: Positron emission tomography for preoperative staging in patients with locally advanced or metastatic colorectal adenocarcinoma in lymph node metastasis Hepato-Gastroenterology 55(82-83): 398-402
Fosså, S.D.; Melsom, H.; Loeb, M. 1986: Metastases from an unknown primary tumor. Diagnostic and prognostic aspects Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(1): 3-5
Schober, O.; Meyer, G.J. 1989: Clinical use of positron emission tomography in tumor patients Zeitschrift für Gastroenterologie. Verhandlungsband 24: 152-154
Imahori, Y.; Sasajima, H.; Mineura, K.; Imahori, Y. 2005: Molecular imaging for brain tumor using positron emission tomography Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 9): 250-257
Kobayashi, N.; Fujita, K.; Fujisawa, T.; Takahashi, H.; Yoneda, M.; Abe, Y.; Inamori, M.; Kirikoshi, H.; Kubota, K.; Saito, S.; Nakajima, A. 2008: Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(1): 65-70
Shen, Y.Y.; Su, C.T.; Chen, G.J.S.; Chen, Y.K.; Liao, A.C.F.; Tsai, F.S. 2003: The value of 18F-fluorodeoxyglucose positron emission tomography with the additional help of tumor markers in cancer screening Neoplasma 50(3): 217-221
Sakai, M.; Kato, H.; Saito, K.; Tanaka, N.; Inose, T.; Kimura, H.; Miyazaki, T.; Kuwano, H. 2008: Clinical applications of 18F-fluorodeoxyglucose positron emission tomography in gastrointestinal stromal tumor of the esophagus International Surgery 93(4): 209-213
Wijsman, R.; Kaanders, J.H.; Oyen, W.J.; Bussink, J. 2013: Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(3): 244-256
Hamaya, K.; Doi, K.; Yoshizawa, S.; Motoi, M. 1988: An immunohistological study of metastatic adenocarcinoma of the lymph node: is it useful in diagnosing a primary tumor? Gan no Rinsho. Japan Journal of Cancer Clinics 34(14): 1956-1960
Ishiguro, T.; Fu, Y.; Sadatou, T.; Shimokawa, N.; Shibamoto, K. 2006: Detection of unknown primary tumor in a patient with cerebellar metastasis using FDG PET-CT: case report No Shinkei Geka. Neurological Surgery 34(10): 1027-1032
Poncini, G.; Nendaz, M. 2010: Approach to fever of unknown origin: the role of positron-emission tomography Revue Medicale Suisse 6(234): 249-253
Schuhmacher, J.; Klivényi, G.; Matys, R.; Stadler, M.; Regiert, T.; Hauser, H.; Doll, J.; Maier-Borst, W.; Zöller, M. 1995: Multistep tumor targeting in nude mice using bispecific antibodies and a gallium chelate suitable for immunoscintigraphy with positron emission tomography Cancer Research 55(1): 115-123
Hu, M.; Li, M.-H.; Kong, L.; Liu, N.-B.; Yang, G.-R.; Yu, J.-M. 2008: (18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin Zhonghua Zhong Liu Za Zhi 30(9): 699-701
Su, N.; Li, C.; Shi, Z.; Yang, X. 2012: Positron emission tomography/computed tomography for detecting cervical nodule metastases of oral and maxillofacial cancer Hua Xi Kou Qiang Yi Xue Za Zhi 30(1): 36-39; 44
Nishi, H.; Nakahara, M.; Kido, T.; Yamanishi, H.; Nakao, K.; Tsujimoto, M. 1999: A case report of gastric carcinoma with complete remission of paraaortic lymph node metastasis by 5'-DFUR and MMC administration after resection of primary tumor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(13): 2069-2071